查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1615105

生物资讯学的全球市场规模:各技术，各用途，各地区，范围及预测

Global Bioinformatics Market Size By Technology (Knowledge Management Tools, Bioinformatics Platforms), By Application (Metabolomics, Molecular Phylogenetics), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

生物资讯市场规模及预测

2022年生物资讯市场规模为102.2亿美元，预计2023年至2030年复合年增长率为16.29%，到2030年将达到397.4亿美元。由于对复杂数据的需求不断增加，测序成本下降对核酸和蛋白质测序的需求不断增加，以及蛋白质组学和基因组学的应用不断增加，全球生物资讯市场预计将很快出现显着增长。此外，政府机构和私人公司的药物发现和开发可能会在估计期间推动市场成长。本研究报告是一份全面评估全球生物资讯市场的市场研究报告。对关键细分市场、趋势、推动因素、市场约束、竞争环境等重要因素进行了深入分析。

全球生物资讯市场的定义

生物资讯学是生物学和资讯科技的组合，它将生物数据与储存、分发和分析资讯的技术相结合，支持包括生物医学在内的多个科学研究领域。使用软体工具进行资料库形成、资料管理、资料仓储、资料探勘等。挖掘此类数据会带来技术发现，用于遗传学和基因组研究。市场上有许多生物资讯学产品。它们的特点是蛋白质功能/分析工具、同源/相似性工具、序列分析工具和其他工具。

该领域涵盖许多创新和专业领域，包括结构基因组学、高效基因组学、DNA 微阵列、比较基因组学和医学资讯。因此，这些问题正在增加生物资讯学的全球市场占有率。相反，对复杂解决方案和系统的需求不断增加、医疗保健中机器学习和人工智慧的整合以及投资于生物资讯解决方案成长的软体公司可以为生物资讯解决方案开发商提供利润丰厚的市场机会。

全球生物资讯市场概况

全球生物资讯市场的成长很大程度上归功于该领域数据和技术的进步，导致这些服务的标准不断提高。许多国家目前正在投资人群测序计划，以了解遗传学与疾病之间的关联。在全球范围内，许多公共和商业机构正在稳步投资生物资讯学领域。尖端 NGS 技术的出现增加了对快速、准确的高效生物资讯工具的需求。

生物资讯学家是参与实验探究的少数科学家。因此，获得易于使用的工具对于利用生物资讯学平台至关重要。许多生物资讯学程式没有用户友好的介面，并且通常需要大量的电脑知识。未来几年，新兴国家在国际公司研发和投资方面的重要性预计将增加，这将为基因组学、代谢组学、精准医学、药物发现和其他市场的成长提供机会和亮点。

次世代定序 (NGS) 技术的快速发展正在产生大量的生物数据，随着 NGS 的使用越来越频繁，此数据量只会增加。在基因组分析中，还有很多材料需要研究，因此数据分析至关重要。因此，生物资讯分析后剩余的数据非常有价值，可以再次使用。现有的解决方案未能令人满意地解决生物资讯学中的数据管理课题。然而，缺乏熟练的人力资源、通用的数据格式以及缺乏廉价且用户友好的工具预计将阻碍预测期内的市场发展。

目录

第1章 全球生物资讯学市场:简介

  • 市场概要
  • 调查范围
  • 前提条件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的调查手法

  • 资料探勘
  • 检验
  • 主要采访
  • 资料来源一览

第4章 全球生物资讯学市场展望

  • 概要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 波特的五力分析
  • 价值链分析

第5章 生物资讯学的全球市场:各技术

  • 概要
  • 知识管理工具
  • 生物资讯学平台
  • 生物资讯学服务

第6章 生物资讯学的全球市场:各用途

  • 概要
  • 代谢体学
  • 分子系统学
  • 转录体学
  • 蛋白质体学
  • 化学资讯学
  • 医药品设计
  • 基因学
  • 其他

第7章 生物资讯学的全球市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 全球其他地区
    • 南美
    • 中东·非洲

第8章 全球生物资讯学市场:竞争情形

  • 概要
  • 各公司的市场排行榜
  • 主要的发展策略

第9章 企业简介

  • Agilent Technologies, Inc.
  • Biomax Informatics AG
  • DNAnexus, Inc.
  • Genedata AG
  • Intrexon Bioinformatics Germany GmbH
  • Illumina Inc.
  • Perkinelmer Inc.
  • Qiagen N.V.
  • Seven Bridges Genomics Inc.
  • Thermo Fisher Scientific, Inc.

第10章 主要发展

  • 产品上市/开发
  • 合併和收购
  • 事业扩大
  • 伙伴关係和合作

第11章 附录

  • 相关调查
简介目录
Product Code: 3765

Bioinformatics Market Size And Forecast

Bioinformatics Market size was valued at USD 10.22 Billion in 2022 and is projected to reach USD 39.74 Billion by 2030, growing at a CAGR of 16.29% from 2023 to 2030. Due to an increase in the demand for combined data, an increase in the demand for nucleic acid and protein sequencing due to a drop in sequencing costs, and an increase in the applications of proteomics and genomics, the Global Bioinformatics Market is predicted to experience significant growth soon. In addition, drug discovery & development and enterprises from government & private organizations are probable to boost the market growth during the estimated period. The Global Bioinformatics Market report provides a holistic evaluation of the market. The research provides a thorough analysis of the market's key segments, trends, drivers, restraints, competitive environment, and other important elements.

Global Bioinformatics Market Definition

Bioinformatics is a grouping of biology and information technology, which links biological data with techniques for information storage, distribution, and analysis to support multiple areas of scientific research, with biomedicine. It uses software tools for database formation, data management, data warehousing, data mining, and others. Mining such data leads to technical discoveries, this is used in the study of genetics & genomes. Numerous bioinformatics implements are presented in the market. They are characterized as protein functional & analysis tools, homology & similarity tools, sequence analysis tools, and miscellaneous tools.

The field covers many innovative and specialized areas of life such as structural genomics, efficient genomics, DNA microarrays, comparative genomics, and medical information. Hence, these aforesaid issues increase the Global Bioinformatics Market share. Conversely, the increase in the need for combined solutions & systems, integration of machine learning & AI in healthcare, and software companies investing in the growth of bioinformatics solutions are predictable to offer remunerative market opportunities to bioinformatics solutions developers.

Global Bioinformatics Market Overview

The growth of the worldwide Bioinformatics Market is largely attributable to data and technological advancements in the field, which have improved the standard of these services. To understand the connection between genetics and diseases, many nations are now investing in their national population sequencing initiatives. Globally, numerous public and commercial institutions are steadily making investments in the field of bioinformatics. With the advent of cutting-edge NGS technology, there is an increasing demand for efficient bioinformatics tools that are speedy and accurate.

Bioinformaticians make up a small majority of the scientists involved in the experimental inquiry. As a result, having access to user-friendly tools is essential for using bioinformatics platforms. Because many bioinformatics programs lack an appropriate user-friendly interface, they frequently require significant computer knowledge. In the upcoming years, it is anticipated that the rising significance of these emerging economies in terms of R&D and investments from international companies will offer a positive outlook-as well as opportunities-for the growth of genomics, metabolomics, precision medicine, drug discovery, and other markets.

A significant amount of biological data has been generated by the quick development of next-generation sequencing (NGS) technology, and this data volume is growing as NGS is used more frequently. Data analysis is essential because there is still a ton of material to be investigated in genomic analysis. As a result, the data that is left over after bioinformatics analysis is extremely valuable and can be used again. The challenges of data management in bioinformatics are not sufficiently addressed by the available solutions. However, a lack of skilled personnel, common data formats, and the absence of user-friendly tools at cheaper prices are projected to hamper the market development during the forecast period.

Global Bioinformatics Market: Segmentation Analysis

The Global Bioinformatics Market is segmented on the basis of Technology, Application, and Geography.

Bioinformatics Market, By Technology

  • Knowledge Management Tools
  • Bioinformatics Platforms
  • Bioinformatics Services

Based on Technology, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatics Services. The bioinformatics platforms sector was the main income and is anticipated to endure this trend during the projected period, owing to a rise in platform applications and the need for better tools in drug development. An increase in platform application is credited to a surge in need from the life science firm for the identification and alteration of structures. This, in chance, would help in the drug scheming process and assessment of their therapeutic effects. Furthermore, competence and safety in drug development and discovery lead to an upsurge in the need for better tools in drug development. Thus, is expected to drive the Bioinformatics Market size in the upcoming.

Bioinformatics Market, By Application

  • Metabolomics
  • Molecular phylogenetics
  • Transcriptomics
  • Proteomics
  • Chemoinformatics & drug design
  • Genomics
  • Others

Based on Application, the market is segmented into Metabolomics, Molecular phylogenetics, Transcriptomics, Proteomics, Chemoinformatics & drug design, Genomics, and Others. The transcriptomics segment is predicted to exhibit the highest growth during the forecast period, owing to an increase in favor of companion diagnostics and personalized medicines. Moreover, novel gene sequencing, uninterrupted detection of biomarkers, and universal acceptance of transcriptomics technology are expected to drive the Bioinformatics Market growth.

Bioinformatics Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, The Global Bioinformatics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America dominated the market, accounting for the highest share, and is anticipated to continue this trend throughout the forecast period. This is recognized as to surge in the adoption of advanced technology and growth in demand for better bioinformatics tools, which are required in the drug discovery and development process. The market in LAMEA is expected to grow at the highest revenue during the forecast period, owing to advancements in the field of genomics and proteomics, producing a massive volume of statistics, which is to be understood and accomplished.

Key Players

  • The "Global Bioinformatics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Agilent Technologies, Inc., Biomax Informatics AG, DNAnexus, Inc., Genedata AG, Intrexon Bioinformatics Germany GmbH, Illumina Inc., Perkinelmer Inc., Qiagen N.V., Seven Bridges Genomics Inc., Thermo Fisher Scientific, Inc.
  • The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In September 2021, Agilent Technologies Inc. has announced an agreement of a global distribution with Visiopharm, which will allow Agilent to co-market Visiopharm's portfolio of CE-IVD obvious AI-driven precision pathology software in addition to its portfolio of automated pathology staining solutions. This partnership, which initially focuses on Europe, represents Agilent's entry into the growing digital pathology sector and improves the relationship between the two businesses by enhancing the possibility of their future cooperation.
  • In April 2022, Logica, a drug resolution driven by artificial intelligence (AI) that directly turns clients' biological insights into improved preclinical assets, was introduced by Charles River and Valo Health. Logica makes use of Charles River's leading preclinical experience and Valo's AI-powered Opal Computational Platform to provide clients with transformed drug development with a single integrated contribution that effortlessly converts scores to candidate submissions.
  • In July 2021, the debut of nRavel, a unique AI discovery platform for oncology and precision medicine, was announced by Indivumed GmbH. The platform integrates IndivuType's rich multi-omics data with a comprehensive set of advanced analytics capabilities, powerful automated machine learning algorithms, and attractive disease models.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL BIOINFORMATICS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL BIOINFORMATICS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL BIOINFORMATICS MARKET, BY TECHNOLOGY

  • 5.1 Overview
  • 5.2 Knowledge Management Tools
  • 5.3 Bioinformatics Platforms
  • 5.4 Bioinformatics Services

6 GLOBAL BIOINFORMATICS MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Metabolomics
  • 6.3 Molecular Phylogenetics
  • 6.4 Transcriptomics
  • 6.5 Proteomics
  • 6.6 Chemoinformatic
  • 6.7 Drug Design
  • 6.8 Genomics
  • 6.9 Others

7 GLOBAL BIOINFORMATICS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East and Africa

8 GLOBAL BIOINFORMATICS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Agilent Technologies, Inc.
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Biomax Informatics AG
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 DNAnexus, Inc.
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Genedata AG
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Intrexon Bioinformatics Germany GmbH
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Illumina Inc.
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Perkinelmer Inc.
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Qiagen N.V.
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Seven Bridges Genomics Inc.
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Thermo Fisher Scientific, Inc.
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

  • 10.1 Product Launches/Developments
  • 10.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 10.4 Partnerships and Collaborations

11 Appendix

  • 11.1 Related Research